Table 1 Clinicopathological features of PRNRP, PRCC1, and PRCC2.
PRNRP (n, 30) | PRCC1 (n, 23) | PRCC2 (n, 26) | PRNRP vs. PRCC1 p value | PRNRP vs. PRCC2 p value | |
|---|---|---|---|---|---|
Age (years, mean ± SD) | 60.6 ± 8.2 | 58.1 ± 9.7 | 62.5 ± 11.1 | 0.314 | 0.474 |
Sex | 0.602 | 0.253 | |||
Female | 11 (36.7%) | 6 (26.1%) | 5 (19.2%) | ||
Male | 19 (63.3%) | 17 (73.9%) | 21 (80.8%) | ||
Tumor size (cm) | 1.8 ± 0.9 | 5.4 ± 4.9 | 5.0 ± 3.8 | 0.002 | < 0.001 |
Multiplicity | 0.358 | 0.087 | |||
1 | 30 (100.0%) | 21 (91.3%) | 22 (84.6%) | ||
2 | 0 (0.0%) | 2 (8.7%) | 4 (15.4%) | ||
Treatment | 0.001 | 0.003 | |||
Partial nephrectomy | 29 (96.7%) | 13 (56.5%) | 16 (61.5%) | ||
Radical nephrectomy | 1 (3.3%) | 10 (43.5%) | 10 (38.5%) | ||
Pathologic T stage | 0.006 | 0.007 | |||
T1a | 30 (100.0%) | 15 (65.2%) | 16 (61.5%) | ||
T1b | 0 (0.0%) | 4 (17.4%) | 4 (15.4%) | ||
T2 | 0 (0.0%) | 2 (8.7%) | 2 (7.6%) | ||
T3a | 0 (0.0%) | 2 (8.7%) | 4 (15.4%) | ||
Survival | 0.593 | 0.017 | |||
Alive | 28 (93.3%) | 23 (100%) | 17 (65.4%) | ||
Dead of disease | 0 (0.0%) | 0 (0.0%) | 5 (19.2%) | ||
Dead of other causes | 2 (6.7%) | 0 (0.0%) | 4 (15.4%) | ||
Follow up (months) | 54.6 ± 47.0 | 47.9 ± 38.0 | 45.5 ± 32.5 | 0.578 | 0.409 |
